A sudden shedding: azathioprine induced anagen effluvium
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20254126Keywords:
Azathioprine, Leucopenia, MyelosuppressionAbstract
Azathioprine is commonly used as immunosuppressive therapy for various autoimmune diseases including Takayasu arteritis. Myelosuppression is a recognized side effect of azathioprine, often requiring dose reduction. However, severe alopecia is rarely encountered. Here, a case of azathioprine-induced anagen effluvium and leucopenia that occurred in a 26-year-old woman with Takayasu arteritis who developed sudden diffuse non-scarring alopecia and leucopenia within three weeks of starting azathioprine therapy.
Metrics
References
Mishra D, Sharma SK, Sharma A, Jain S, Dhir V. Alopecia as the First Manifestation of Azathioprine Myelosuppression in a Genetically Predisposed Patient. Indian J Rheumatol. 2019;14(1):61-4. DOI: https://doi.org/10.4103/injr.injr_127_18
Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW. Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(5):715-29. DOI: https://doi.org/10.1111/j.1365-2036.2006.02980.x
Mertens HG, Hertel G, Reuther P, Ricker K. Effect of immunosuppressive drugs (azathioprine). Ann N Y Acad Sci. 1981;377:691-9. DOI: https://doi.org/10.1111/j.1749-6632.1981.tb33767.x
Jensen CH, Tiu J, Catalanotti JS. Azathioprine-induced pancytopenia with normal TPMT activity presenting with HSV oral ulcers. BMJ Case Rep. 2018;2018:bcr2018225209. DOI: https://doi.org/10.1136/bcr-2018-225209
Dutta N, Babu D, Ramaswamy D, Mamadapur D. Alopecia as an Early Clinical Marker for Azathioprine Induced Myelosuppression: A Case Report. Digital J Clin Med. 2024;6(1).
Valerie NC, Hagenkort A, Page BD, Masuyer G, Rehling D, Carter M, et al. NUDT15 hydrolyzes 6 Thio DeoxyGTP to mediate the anticancer efficacy of 6 Thioguanine. Cancer Res. 2016;76:5501-11. DOI: https://doi.org/10.1158/0008-5472.CAN-16-0584
Kim JC, Kim YK, Hyun HS, Park EJ, Kang HG, Ha IS, et al. A case of azathioprine induced severe myelosuppression and alopecia totalis in Iga nephropathy. Child Kidney Dis. 2017;21:35-9. DOI: https://doi.org/10.3339/jkspn.2017.21.1.35
Bhokare AB. Azathioprine induced alopecia as an early clinical marker of its myelotoxicity. Indian J Drugs Dermatol. 2017;3:40-1. DOI: https://doi.org/10.4103/ijdd.ijdd_4_17
Chen D, Lian F, Yuan S, Wang Y, Zhan Z, Ye Y, et al. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus. Clin Rheumatol. 2014;33:499-503. DOI: https://doi.org/10.1007/s10067-013-2441-x
Lee YJ, Hwang EH, Park JH, Shin JH, Kang B, Kim SY. NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease. Eur J Gastroenterol Hepatol. 2016;28(4):475-8. DOI: https://doi.org/10.1097/MEG.0000000000000564
Downloads
Published
How to Cite
Issue
Section
